Charles Nock is an Oncology physician. OpenAlex indexes 22 publications with 504 citations (h-index 11); ClinicalTrials.gov lists 2 registered studies matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Publications indexed by OpenAlex. Counts exclude supporting files.
Citations across these publications.
H-index from these publications.
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
- Tocilizumab Combined With First-Line Chemo-Immunotherapy in Metastatic Non-Small Cell Lung Cancer
Sponsor: VA Office of Research and Development
Overall officialPhase 1/PHASE2Not, yet, recruitingNCT07889232 - GDC-0449 in Treating Patients With Recurrent Glioblastoma Multiforme That Can Be Removed by Surgery
Sponsor: National Cancer Institute (NCI)
- Dasatinib in Treating Patients With Metastatic Pancreatic Cancer
Sponsor: National Cancer Institute (NCI)
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
1 company reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Bristol Myers SquibbProgram year20252 paymentsResearch$30,516openpaymentsdata.cms.gov ↗
- NovartisProgram year20251 paymentResearch
- NovartisProgram year20241 paymentResearch
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward. Research funding is listed under each investigator the record names.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Restrictive trial eligibility criteria as a barrier to clinical trial enrollment among veterans with aerodigestive cancers.
Journal of Clinical Oncology
2026 - Baseline IL-6, IL-8, IFN-ω, and perforin as prognostic biomarkers in immune checkpoint inhibitor-treated metastatic non-small cell lung cancer
Translational Lung Cancer Research
2026 - Centralizing Community Care Referrals at a VA Lung Cancer Screening Program
American Journal of Respiratory and Critical Care Medicine
2025 - Novel imaging biomarkers predict outcomes in stage III unresectable non-small cell lung cancer treated with chemoradiation and durvalumab
Journal for ImmunoTherapy of Cancer
2022
Similar KOLs
Other experts from the same institution or the same specialty.
No other directory profiles share this institution yet.
Carl June, MD
University of Pennsylvania
Rainer Storb
University of Washington
Christina Fitzmaurice, MD
Beth Karlan, MD
University of California, Los Angeles
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”